Osiris Announces Enrollment of Patients in a Clinical Trial Evaluating GrafixPL PRIME(TM) in the Treatment of Chronic Venous Leg Ulcers
Stock Information for Osiris Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.